China Life Private Equity Investment
Shanghai, Shanghaiclpe.com.cn
Overview
China Life Private Equity Investment Co., Ltd. is the professional private equity investment platform under the China Life Group, established in June 2016. The firm focuses on long-term value investing and manages funds, including the flagship China Life Healthcare Fund. Its primary investment areas are healthcare (including life sciences, med-tech, and digital health) and technology (including AI and semiconductors). The firm is registered in the Shanghai Free Trade Zone and is an active investor in the Chinese market.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cascade Pharmaceuticals, Inc. | Feb 2026 | Early Funding | Co-investor |
| Jiangsu Vcare Pharmatech | Jan 2024 | Series C | Lead |
| Hithium | Jun 2023 | Series C | Lead |
| Xi'an Eswin Material Technology Co., Ltd. | Dec 2022 | Series C | Co-investor |
| Xi'an Eswin Material Technology Co., Ltd. | Jul 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.